MENU
VNRX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

VolitionRX (VNRX) Earnings Date & Reports

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19... Show more

A.I. Advisor
published Earnings

VNRX is expected to report earnings to fall 32.00% to -3 cents per share on March 31

VolitionRX VNRX Stock Earnings Reports
Q4'25
Est.
$-0.03
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.02
Q4'24
Est.
$-0.05
The last earnings report on November 13 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 521.38K shares outstanding, the current market capitalization sits at 40.24M.
View a ticker or compare two or three
VNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VNRX showed earnings on November 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a development stage life sciences company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1489 West Warm Springs Road
Phone
+1 646 650-1351
Employees
110
Web
https://www.volition.com